FINWIRES · TerminalLIVE
FINWIRES

Northland Securities Downgrades Calix to Market Perform From Outperform, Adjusts Price Target to $52 From $75

-- Calix (CALX) has an average rating of overweight and mean price target of $67, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Australia

UBS Adjusts Price Target on Tapestry to $142 From $141, Maintains Neutral Rating

Tapestry (TPR) has an average rating of overweight and mean price target of $165.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $148.33, Change: $+2.15, Percent Change: +1.47%

$TPR
Australia

Oppenheimer Adjusts Boston Scientific Price Target to $90 From $100, Maintains Outperform Rating

Boston Scientific (BSX) has an average rating of Buy and mean price target of $87.23, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $65.88, Change: $+1.01, Percent Change: +1.55%

$BSX
Research

B. Riley Downgrades Century Communities to Neutral From Buy, Cuts Price Target to $64 From $75

Price: $56.30, Change: $-7.53, Percent Change: -11.80%

$CCS